Mohsen Afarideh, MD MPH

Mohsen Afarideh, MD MPH

Department of Dermatology, Mayo Clinic
在 mayo.edu 的电子邮件经过验证
被引用次数：74098
Dermatology Epidemiology Therapeutic Targets Randomized Controlled Trials
Rui Su

Rui Su

City of Hope
在 coh.org 的电子邮件经过验证
被引用次数：11205
Leukemia Epitranscriptomics Therapeutic targets Drug development Immune response
Kalavathy Ramasamy

Kalavathy Ramasamy

Universiti Teknologi MARA
在 salam.uitm.edu.my 的电子邮件经过验证
被引用次数：6765
Therapeutic targets
Mark Avigan

Mark Avigan

Associate Office Director, FDA & Professor (Adjunct), Georgetown U. School of Medicine
在 fda.hhs.gov 的电子邮件经过验证
被引用次数：6281
Liver Disease Molecular Science Therapeutic targets Drug-induced liver injury
Yong Weon Yi, Ph.D.

Yong Weon Yi, Ph.D.

College of Medicine, Dankook University
在 dankook.ac.kr 的电子邮件经过验证
被引用次数：3272
protein kinase inhibitors therapeutic targets extracellular vesicles anticancer triple negative breast cancer
Bashdar Mahmud Hussen

Bashdar Mahmud Hussen

College of Pharmacy, Hawler Medical University, Kurdistan region, Iraq
在 hmu.edu.krd 的电子邮件经过验证
被引用次数：3182
Cancer Non-coding RNA Therapeutic targets
Julie Decock

Julie Decock

Qatar Biomedical Research Institute (QBRI)
在 hbku.edu.qa 的电子邮件经过验证
被引用次数：2916
breast cancer cancer testis antigens tumor-immune ecosystem therapeutic targets
Paul Nguewa

Paul Nguewa

Universidad de Navarra
在 unav.es 的电子邮件经过验证
被引用次数：2251
leishmania drug therapeutic targets cancer
Feiya Li

Feiya Li

Gladstone Institute
在 gladstone.ucsf.edu 的电子邮件经过验证
被引用次数：1379
heart development therapeutic targets cardiovascular various diseases biomarker
Kesmic Jackson

Kesmic Jackson

在 dendreon.com 的电子邮件经过验证
被引用次数：562
Bioassays Biomarkers Therapeutic Targets Immune Response Methylation
1 - 10